Filing status
- Accounts due
- 28 February 2027
- Last accounts
- 31 May 2025
- Conf. stmt due
- 19 May 2027
- Last conf. stmt
- 5 May 2026
Dysruptx Ltd
- Incorporated
- 6 May 2022 (4 years)
- Previously known as
- Disruptyx Therapeutics Limited (until 29 September 2025)Disruptyve Therapeutics Limited (until 19 May 2022)This list may be incomplete. See all names on Companies House
- Industry
- Research and experimental development on biotechnology (72110)
- Owned by
- George Scott BaillieConnor Macleod Blair
- Accounts type
- Dormant
- Region
- Scotland
- Address
- 11 The SquareUniversity AvenueGlasgowG12 8QQ
Officers
Not loaded yet. See them on Companies House
Ownership 2 active
People and entities with significant control, from the Companies House PSC register
George Scott Baillie
Individual · Notified 12 September 2022
Owns 25–50% of shares
Holds 25–50% of voting rights
British
Born December 1966 (59)
Connor Macleod Blair
Individual · Notified 12 September 2022
Owns 50–75% of shares
Owns 50–75% of shares (as a firm)
Holds 50–75% of voting rights
Holds 50–75% of voting rights (as a firm)
Right to appoint and remove directors
Right to appoint and remove directors (as a firm)
British
Born May 1993 (33)
Former controllers (1)
14 March 2025
Ceased Douglas Fraser Gray — Owns 25–50% of shares
Financials
Balance sheet as at 31 May 2025 · dormant accounts · dormant
- Net Assets
- £150
- Cash
- £150
Trend
Net Assets
Balance sheet detail
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Cash | £150 | £150 | £150 |
| Net Assets | £150 | £150 | £150 |
| Shareholder Funds | £150 | £150 | £150 |
Filings
Filing history not loaded yet. See it on Companies House
Some other companies at this address
Other companies in this industry
Cambridge
Cambridge
Abingdon
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →